Profile | GDS5420 / 230922_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 240.31 | 55 |
GSM1296119 | B_lesional_pre-dose | 327.38 | 61 |
GSM1296076 | C_lesional_pre-dose | 425.53 | 66 |
GSM1296092 | D_lesional_pre-dose | 270.9 | 59 |
GSM1296103 | E_lesional_pre-dose | 175.59 | 51 |
GSM1296078 | F_lesional_pre-dose | 345.63 | 63 |
GSM1296107 | G_lesional_pre-dose | 232.84 | 54 |
GSM1296109 | H_lesional_pre-dose | 177.75 | 49 |
GSM1296080 | I_lesional_pre-dose | 265.79 | 58 |
GSM1296090 | J_lesional_pre-dose | 288.91 | 59 |
GSM1296074 | K_lesional_pre-dose | 343.66 | 63 |
GSM1296111 | L_lesional_pre-dose | 321.56 | 60 |
GSM1296099 | M_lesional_pre-dose | 234.56 | 55 |
GSM1296086 | O_lesional_pre-dose | 301.87 | 60 |
GSM1296117 | P_lesional_pre-dose | 228 | 54 |
GSM1296113 | Q_lesional_pre-dose | 316.99 | 59 |
GSM1296096 | R_lesional_pre-dose | 264.92 | 57 |
GSM1296105 | S_lesional_pre-dose | 254.6 | 56 |
GSM1296098 | T_lesional_pre-dose | 193.11 | 51 |
GSM1296101 | U_lesional_pre-dose | 270.64 | 57 |
GSM1296121 | V_lesional_pre-dose | 263.9 | 57 |
GSM1296088 | W_lesional_pre-dose | 249.94 | 57 |
GSM1296082 | X_lesional_pre-dose | 240.93 | 57 |
GSM1296115 | Y_lesional_pre-dose | 183.68 | 50 |
GSM1296084 | Z_lesional_pre-dose | 319.6 | 60 |
GSM1296072 | B_lesional_day8 | 356.97 | 62 |
GSM1296069 | L_lesional_day8 | 292.04 | 57 |
GSM1296071 | P_lesional_day8 | 328.73 | 59 |
GSM1296070 | Y_lesional_day8 | 311.07 | 59 |
GSM1296073 | V_lesional_day8 | 270.56 | 58 |
GSM1296034 | A_lesional_day15 | 329.42 | 60 |
GSM1296041 | G_lesional_day15 | 332.75 | 61 |
GSM1296035 | R_lesional_day15 | 236.57 | 55 |
GSM1296038 | U_lesional_day15 | 188.19 | 51 |
GSM1296047 | B_lesional_day15 | 409.88 | 64 |
GSM1296039 | E_lesional_day15 | 258.59 | 57 |
GSM1296042 | H_lesional_day15 | 279.82 | 57 |
GSM1296043 | L_lesional_day15 | 312.57 | 59 |
GSM1296037 | M_lesional_day15 | 307.84 | 59 |
GSM1296046 | P_lesional_day15 | 362.68 | 61 |
GSM1296044 | Q_lesional_day15 | 361.27 | 61 |
GSM1296045 | Y_lesional_day15 | 332.65 | 60 |
GSM1296025 | C_lesional_day15 | 405.87 | 64 |
GSM1296033 | D_lesional_day15 | 294.29 | 59 |
GSM1296027 | I_lesional_day15 | 323.29 | 61 |
GSM1296032 | J_lesional_day15 | 350.08 | 61 |
GSM1296024 | K_lesional_day15 | 359.75 | 62 |
GSM1296031 | W_lesional_day15 | 373.35 | 62 |
GSM1296028 | X_lesional_day15 | 298.35 | 59 |
GSM1296029 | Z_lesional_day15 | 292.08 | 58 |
GSM1296026 | F_lesional_day15 | 246.21 | 57 |
GSM1296030 | O_lesional_day15 | 311.34 | 61 |
GSM1296040 | S_lesional_day15 | 189.88 | 51 |
GSM1296036 | T_lesional_day15 | 202.32 | 51 |
GSM1296048 | V_lesional_day15 | 286.49 | 58 |
GSM1296059 | A_lesional_day43 | 196.83 | 53 |
GSM1296066 | G_lesional_day43 | 306.8 | 59 |
GSM1296060 | R_lesional_day43 | 298.55 | 59 |
GSM1296063 | U_lesional_day43 | 269.58 | 57 |
GSM1296064 | E_lesional_day43 | 210.9 | 54 |
GSM1296067 | H_lesional_day43 | 310.75 | 58 |
GSM1296062 | M_lesional_day43 | 244.73 | 55 |
GSM1296068 | Q_lesional_day43 | 339.1 | 60 |
GSM1296050 | C_lesional_day43 | 446.72 | 66 |
GSM1296057 | D_lesional_day43 | 405.03 | 64 |
GSM1296052 | I_lesional_day43 | 376.35 | 63 |
GSM1296054 | J_lesional_day43 | 332.65 | 60 |
GSM1296049 | K_lesional_day43 | 370.68 | 63 |
GSM1296055 | W_lesional_day43 | 392.67 | 63 |
GSM1296053 | X_lesional_day43 | 381.2 | 63 |
GSM1296058 | Z_lesional_day43 | 265.41 | 57 |
GSM1296051 | F_lesional_day43 | 354.44 | 63 |
GSM1296056 | O_lesional_day43 | 227.9 | 55 |
GSM1296065 | S_lesional_day43 | 364.64 | 62 |
GSM1296061 | T_lesional_day43 | 207.83 | 52 |
GSM1296095 | A_non-lesional_pre-dose | 281.32 | 58 |
GSM1296120 | B_non-lesional_pre-dose | 385.7 | 63 |
GSM1296077 | C_non-lesional_pre-dose | 382.32 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 283.97 | 57 |
GSM1296104 | E_non-lesional_pre-dose | 381.58 | 63 |
GSM1296079 | F_non-lesional_pre-dose | 395.49 | 64 |
GSM1296108 | G_non-lesional_pre-dose | 354.44 | 62 |
GSM1296110 | H_non-lesional_pre-dose | 329.76 | 59 |
GSM1296081 | I_non-lesional_pre-dose | 374.49 | 63 |
GSM1296091 | J_non-lesional_pre-dose | 410.48 | 65 |
GSM1296075 | K_non-lesional_pre-dose | 463.5 | 67 |
GSM1296112 | L_non-lesional_pre-dose | 354.63 | 61 |
GSM1296100 | M_non-lesional_pre-dose | 311.33 | 59 |
GSM1296087 | O_non-lesional_pre-dose | 320.35 | 61 |
GSM1296118 | P_non-lesional_pre-dose | 381.98 | 62 |
GSM1296114 | Q_non-lesional_pre-dose | 338.58 | 60 |
GSM1296097 | R_non-lesional_pre-dose | 313.78 | 60 |
GSM1296106 | S_non-lesional_pre-dose | 360.09 | 61 |
GSM1296102 | U_non-lesional_pre-dose | 282.63 | 57 |
GSM1296122 | V_non-lesional_pre-dose | 386.08 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 332.17 | 60 |
GSM1296083 | X_non-lesional_pre-dose | 359.12 | 62 |
GSM1296116 | Y_non-lesional_pre-dose | 340.04 | 60 |
GSM1296085 | Z_non-lesional_pre-dose | 306.69 | 59 |